Myferon 150 Forte

Product NDC: 58607-112
11-digit product format: 586070112
Labeler code: 58607
Product ID: 58607-112_24af9e28-be37-44a7-89c9-629f29b621e9
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN
Dosage form: CAPSULE
Route: ORAL
Labeler: MARTIN EKWEALOR PHARMACEUTICALS, INC.
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 1996-12-01
Marketing end: 0000-00-00
Substance: IRON SUCROSE; FOLIC ACID; CYANOCOBALAMIN
Active strength: 150 mg/1; mg/1; ug/1
Pharmacologic classes: Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B 12 [CS],Vitamin B12 [EPC]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	58607-112		I	Inactivated by FDA		2026-10-12
excluded package	package	58607-112	58607-112-00	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58607-112-00	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58607-112-00	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58607-112-00	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58607-112-00	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58607-112-00	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58607-112-00	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58607-112-00	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58607-112-00	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58607-112-00	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58607-112-00	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58607-112-00	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58607-112-00	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	58607-112-00	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	58607-112-00	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	58607-112-00	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	58607-112-00	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	58607-112-00	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	58607-112-00	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58607-112-00	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58607-112-00	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	58607-112-00	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	58607-112-00	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b82b4008-22fd-05f5-6cc6-c0a6e81c65b8	Product name	2	20240805
04cdd491-d111-4bc2-9549-75c575e1bd4b	Product name	1	20200714
8390fb8b-6c75-416c-a9a1-70e8ed493b73	Product name	1	20200611
91c62db0-0295-c81c-d10a-0856c259edd6	Product name	2	20200428
96a528e9-23e2-495f-81b9-ae87df2f7552	Product name	1	20191120
d32bc2b8-0bb7-2216-87aa-24639646e202	Product name	3	20190619
d206bb34-ea65-399d-70d9-834f22dc2c18	Product name	3	20170724
3df56c93-5837-4523-aac2-4b1ec48b9676	Product name	2	20160719
a883b7cc-d320-41d7-92ae-c873457ae641	Product name	1	20151116
bb23e78e-9e64-4037-a1c1-0e1d8762700e	Product name	1	20150325
ef06c001-572c-d95e-42f6-ee83da75673a	Product name	1	20140508
fd21f957-6863-d07b-5a35-250186878716	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
58607-112-00	2019-11-27	C162847	48780-1	9855e2a2-3fbd-60a7-e053-dbdaa90a05bd	ed2308e3-5310-41bd-9333-615c26183493

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
58607-112-00	Myferon 150 Forte	10 in 1 BLISTER PACK	CAPSULE	10		2
58607-112-00	Myferon 150 Forte	100 in 1 BOX	CAPSULE	100		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58607-112-00	EA - Each	58607-112	ab9d8a74-741b-4138-8079-7aaa95aa1f49	1	2014-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CYANOCOBALAMIN	ACTIVE INGREDIENT	P6YC3EG204	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
FOLIC ACID	ACTIVE INGREDIENT	935E97BOY8	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
IRON SUCROSE	ACTIVE INGREDIENT	FZ7NYF5N8L	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
CYANOCOBALAMIN	ACTIVE MOIETY	P6YC3EG204	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
FERRIC CATION	ACTIVE MOIETY	91O4LML611	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
FOLIC ACID	ACTIVE MOIETY	935E97BOY8	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	L11K75P92J	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58607-112	MYFERON 150 FORTE (IRON SUCROSE, FOLIC ACID, CYANOCOBALAMIN) CAPSULE [MARTIN EKWEALOR PHARMACEUTICALS, INC.]	2	Legacy NDC, 2 package rows	20140306_ed2308e3-5310-41bd-9333-615c26183493.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
FZ7NYF5N8L	IRON SUCROSE	8047-67-4	IRON SUCROSE
935E97BOY8	FOLIC ACID	59-30-3	FOLIC ACID
P6YC3EG204	CYANOCOBALAMIN	68-19-9	CYANOCOBALAMIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
309606	polysaccharide iron complex (iron) 150 MG / folic acid 1 MG / vitamin B12 25 MCG Oral Capsule	PSN	ed2308e3-5310-41bd-9333-615c26183493	2
309606	folic acid 1 MG / polysaccharide iron complex 150 MG / vitamin B12 0.025 MG Oral Capsule	SCD	ed2308e3-5310-41bd-9333-615c26183493	2
309606	cyanocobalamin 25 MCG / folic acid 1 MG / polysaccharide iron complex 150 MG Oral Capsule	SY	ed2308e3-5310-41bd-9333-615c26183493	2
309606	folate 1 MG / polysaccharide iron complex 150 MG / vitamin B12 0.025 MG Oral Capsule	SY	ed2308e3-5310-41bd-9333-615c26183493	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
58607-112-00	58607011200	10 in 1 BLISTER PACK	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Myferon 150 Forte - MARTIN EKWEALOR PHARMACEUTICALS, INC.	MARTIN EKWEALOR PHARMACEUTICALS, INC.	2014-02-20	HUMAN PRESCRIPTION DRUG LABEL	2